Novartis Licenses GeneData Expressionist System for Microarray Data Analysis | GenomeWeb

 

Novartis Licenses GeneData’s Expressionist System for Microarray Data Analysis

 

 

NEW YORK, Feb 15 – Basel, Switzerland-based bioinformatics company GeneData said Thursday it has entered into a multi-year license agreement with Novartis Pharma AG for its Expressionist microarray data analysis system. 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.